Kreitchman PET Center
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 722 W 168 St (R-1 Level), New York, New York (NY) 10032, United States (USA)
- Operations here
- positron emission tomography drug production
- FDA identifiers
- FEI 3009498040 · DUNS 010861487
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2017-12-15
Drugs this plant is listed as making
4 distinct drugs across 4 products name this site in their FDA label.
- Ammonia N-13Kreitchman PET Center
- Fludeoxyglucose F18Kreitchman PET Center
- Fluoroestradiol F 18GE Healthcare Inc.
- Sodium Fluoride F-18Kreitchman PET Center
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.